Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Encephalomyelitis, Autoimmune, Experimental | 33 | 2024 | 53 | 8.310 |
Why?
|
Multiple Sclerosis | 22 | 2024 | 43 | 6.410 |
Why?
|
Autoimmune Diseases | 8 | 2020 | 55 | 2.590 |
Why?
|
Peptide Fragments | 19 | 2021 | 298 | 2.430 |
Why?
|
Pertussis Toxin | 9 | 2013 | 27 | 2.090 |
Why?
|
Th1 Cells | 15 | 2018 | 87 | 2.080 |
Why?
|
Lymphocyte Activation | 15 | 2021 | 222 | 2.010 |
Why?
|
T-Lymphocytes | 17 | 2018 | 341 | 2.010 |
Why?
|
Myelin Proteolipid Protein | 8 | 2021 | 12 | 1.780 |
Why?
|
Adjuvants, Immunologic | 6 | 2021 | 106 | 1.730 |
Why?
|
Cytokines | 15 | 2016 | 569 | 1.720 |
Why?
|
T-Lymphocyte Subsets | 10 | 2014 | 84 | 1.690 |
Why?
|
Central Nervous System | 9 | 2021 | 130 | 1.550 |
Why?
|
Mice | 65 | 2024 | 5668 | 1.510 |
Why?
|
CD4-Positive T-Lymphocytes | 13 | 2020 | 251 | 1.470 |
Why?
|
Animals | 79 | 2024 | 14307 | 1.450 |
Why?
|
Interferon-gamma | 16 | 2016 | 235 | 1.340 |
Why?
|
Th2 Cells | 11 | 2014 | 56 | 1.300 |
Why?
|
Mice, Inbred C57BL | 29 | 2024 | 1530 | 1.260 |
Why?
|
HLA-DR4 Antigen | 7 | 2018 | 20 | 1.240 |
Why?
|
HLA-DR2 Antigen | 3 | 2018 | 4 | 1.220 |
Why?
|
Epitopes, T-Lymphocyte | 13 | 2013 | 55 | 1.190 |
Why?
|
Freund's Adjuvant | 10 | 2021 | 14 | 1.180 |
Why?
|
Antigen Presentation | 8 | 2021 | 54 | 1.150 |
Why?
|
Mice, Transgenic | 20 | 2020 | 608 | 1.100 |
Why?
|
Inflammation | 5 | 2019 | 577 | 1.050 |
Why?
|
Immunologic Memory | 7 | 2020 | 38 | 1.020 |
Why?
|
Myelin-Associated Glycoprotein | 6 | 2011 | 17 | 0.970 |
Why?
|
Autoimmunity | 9 | 2013 | 52 | 0.960 |
Why?
|
Multiple Sclerosis, Chronic Progressive | 2 | 2019 | 2 | 0.910 |
Why?
|
Quorum Sensing | 1 | 2022 | 13 | 0.880 |
Why?
|
Astrocytes | 2 | 2019 | 203 | 0.880 |
Why?
|
Lipids | 5 | 2014 | 222 | 0.870 |
Why?
|
Cell Wall | 2 | 2021 | 53 | 0.840 |
Why?
|
Capsules | 1 | 2021 | 24 | 0.810 |
Why?
|
Proteoglycans | 1 | 2021 | 46 | 0.790 |
Why?
|
Myeloid Cells | 3 | 2021 | 28 | 0.790 |
Why?
|
Antigen-Presenting Cells | 7 | 2015 | 30 | 0.750 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 1 | 2019 | 12 | 0.740 |
Why?
|
Saccharomyces cerevisiae | 1 | 2021 | 193 | 0.720 |
Why?
|
Macrophage Migration-Inhibitory Factors | 4 | 2016 | 8 | 0.700 |
Why?
|
Bacteria | 1 | 2022 | 245 | 0.700 |
Why?
|
Antibodies, Monoclonal | 6 | 2022 | 282 | 0.700 |
Why?
|
Antigens | 3 | 2018 | 56 | 0.690 |
Why?
|
Humans | 45 | 2022 | 34853 | 0.690 |
Why?
|
B-Lymphocyte Subsets | 1 | 2018 | 16 | 0.680 |
Why?
|
Neuroglia | 1 | 2019 | 117 | 0.650 |
Why?
|
Cancer Vaccines | 1 | 2017 | 21 | 0.630 |
Why?
|
Cell Differentiation | 5 | 2020 | 562 | 0.620 |
Why?
|
HLA-DR Antigens | 6 | 2011 | 20 | 0.620 |
Why?
|
Disease Models, Animal | 10 | 2024 | 1300 | 0.610 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 2 | 2009 | 94 | 0.610 |
Why?
|
Cell Lineage | 2 | 2020 | 88 | 0.590 |
Why?
|
Francisella tularensis | 6 | 2016 | 115 | 0.570 |
Why?
|
Spinal Cord | 3 | 2013 | 85 | 0.570 |
Why?
|
Proteomics | 6 | 2021 | 302 | 0.550 |
Why?
|
Myelin Sheath | 1 | 2015 | 42 | 0.540 |
Why?
|
Mice, Knockout | 13 | 2018 | 897 | 0.530 |
Why?
|
Bacterial Vaccines | 7 | 2016 | 122 | 0.530 |
Why?
|
Cells, Cultured | 12 | 2021 | 1442 | 0.530 |
Why?
|
Interleukin-17 | 5 | 2016 | 54 | 0.530 |
Why?
|
Lipid Peroxidation | 1 | 2015 | 131 | 0.520 |
Why?
|
Allergy and Immunology | 1 | 2015 | 11 | 0.520 |
Why?
|
Body Fluids | 1 | 2014 | 15 | 0.520 |
Why?
|
Female | 39 | 2024 | 19873 | 0.500 |
Why?
|
Lipid Metabolism | 1 | 2014 | 109 | 0.490 |
Why?
|
Mast Cells | 5 | 2013 | 77 | 0.480 |
Why?
|
Chlamydia Infections | 6 | 2013 | 196 | 0.480 |
Why?
|
Immunotherapy | 2 | 2017 | 91 | 0.470 |
Why?
|
Transcription Factors | 1 | 2018 | 653 | 0.460 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2011 | 150 | 0.450 |
Why?
|
Chlamydia muridarum | 6 | 2013 | 104 | 0.440 |
Why?
|
Mice, Inbred Strains | 8 | 2013 | 117 | 0.430 |
Why?
|
Proteins | 1 | 2014 | 352 | 0.420 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 2 | 2009 | 97 | 0.420 |
Why?
|
Virulence Factors, Bordetella | 2 | 2002 | 7 | 0.420 |
Why?
|
Thymus Gland | 2 | 2009 | 77 | 0.410 |
Why?
|
Neurons | 1 | 2019 | 1130 | 0.410 |
Why?
|
T-Box Domain Proteins | 1 | 2011 | 7 | 0.400 |
Why?
|
Integrin alpha4beta1 | 1 | 2011 | 5 | 0.400 |
Why?
|
Anaphylaxis | 1 | 2011 | 14 | 0.400 |
Why?
|
RNA, Messenger | 1 | 2014 | 1152 | 0.370 |
Why?
|
Mice, Inbred BALB C | 14 | 2016 | 649 | 0.370 |
Why?
|
Interleukin-4 | 6 | 2012 | 69 | 0.370 |
Why?
|
MicroRNAs | 1 | 2014 | 386 | 0.360 |
Why?
|
Proteome | 4 | 2017 | 132 | 0.350 |
Why?
|
Cell Movement | 5 | 2013 | 545 | 0.340 |
Why?
|
Immunization | 6 | 2013 | 90 | 0.340 |
Why?
|
Immune Tolerance | 6 | 2008 | 61 | 0.340 |
Why?
|
Myelin Proteins | 6 | 2011 | 26 | 0.320 |
Why?
|
Neoplasms | 1 | 2017 | 1033 | 0.320 |
Why?
|
Tularemia | 6 | 2016 | 114 | 0.310 |
Why?
|
Brain | 3 | 2013 | 1268 | 0.300 |
Why?
|
Apoptosis | 3 | 2015 | 1317 | 0.300 |
Why?
|
Cell Survival | 1 | 2009 | 818 | 0.290 |
Why?
|
Adoptive Transfer | 5 | 2013 | 48 | 0.280 |
Why?
|
Animals, Newborn | 5 | 2010 | 323 | 0.280 |
Why?
|
Signal Transduction | 5 | 2022 | 1802 | 0.270 |
Why?
|
Genital Diseases, Female | 3 | 2011 | 37 | 0.270 |
Why?
|
Interleukin-6 | 3 | 2021 | 140 | 0.260 |
Why?
|
Injections, Intraperitoneal | 5 | 2013 | 58 | 0.250 |
Why?
|
Antigens, Bacterial | 3 | 2010 | 129 | 0.250 |
Why?
|
Adenosine Triphosphate | 2 | 2019 | 180 | 0.250 |
Why?
|
Immunodominant Epitopes | 5 | 2012 | 27 | 0.250 |
Why?
|
Suramin | 1 | 2004 | 3 | 0.250 |
Why?
|
GTP-Binding Proteins | 1 | 2004 | 57 | 0.240 |
Why?
|
B-Lymphocytes | 2 | 2014 | 181 | 0.220 |
Why?
|
Tumor Necrosis Factor-alpha | 4 | 2016 | 325 | 0.220 |
Why?
|
Receptors, Cytokine | 2 | 2013 | 11 | 0.220 |
Why?
|
Cross Infection | 1 | 2022 | 38 | 0.220 |
Why?
|
Acinetobacter baumannii | 1 | 2022 | 33 | 0.220 |
Why?
|
Immune System | 1 | 2022 | 40 | 0.220 |
Why?
|
Autoantigens | 7 | 2005 | 82 | 0.210 |
Why?
|
Cell Count | 1 | 2022 | 129 | 0.210 |
Why?
|
Dietary Supplements | 1 | 2024 | 196 | 0.210 |
Why?
|
Mammals | 1 | 2022 | 96 | 0.210 |
Why?
|
Flow Cytometry | 3 | 2015 | 392 | 0.210 |
Why?
|
Incidence | 2 | 2024 | 882 | 0.200 |
Why?
|
Integrin alpha4 | 1 | 2021 | 2 | 0.200 |
Why?
|
Serum Amyloid A Protein | 1 | 2021 | 14 | 0.200 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 1 | 2021 | 23 | 0.200 |
Why?
|
Systems Biology | 1 | 2020 | 20 | 0.190 |
Why?
|
Antigens, CD | 1 | 2021 | 116 | 0.190 |
Why?
|
Cell Communication | 2 | 2019 | 93 | 0.190 |
Why?
|
Injections, Subcutaneous | 3 | 2013 | 34 | 0.190 |
Why?
|
STAT3 Transcription Factor | 1 | 2021 | 80 | 0.190 |
Why?
|
Integrins | 1 | 2020 | 49 | 0.190 |
Why?
|
Organ Specificity | 3 | 2018 | 123 | 0.180 |
Why?
|
Recombination, Genetic | 1 | 2020 | 90 | 0.180 |
Why?
|
Zebrafish Proteins | 1 | 2020 | 45 | 0.180 |
Why?
|
Disease Progression | 2 | 2019 | 580 | 0.180 |
Why?
|
Immunoglobulin G | 6 | 2007 | 232 | 0.180 |
Why?
|
NADP | 1 | 2019 | 24 | 0.170 |
Why?
|
Mice, SCID | 4 | 2011 | 143 | 0.170 |
Why?
|
Genomics | 1 | 2020 | 201 | 0.170 |
Why?
|
Antigens, CD20 | 1 | 2018 | 4 | 0.170 |
Why?
|
Interleukin-12 | 3 | 2010 | 46 | 0.170 |
Why?
|
Glucans | 1 | 2018 | 6 | 0.170 |
Why?
|
Neuralgia | 1 | 2019 | 13 | 0.170 |
Why?
|
Protozoan Vaccines | 1 | 2018 | 15 | 0.170 |
Why?
|
Chitin | 1 | 2018 | 19 | 0.170 |
Why?
|
Muramidase | 5 | 2004 | 18 | 0.170 |
Why?
|
Coccidioides | 1 | 2018 | 51 | 0.160 |
Why?
|
Coccidioidomycosis | 1 | 2018 | 46 | 0.160 |
Why?
|
Spleen | 6 | 2016 | 192 | 0.160 |
Why?
|
Vaccination | 3 | 2017 | 259 | 0.160 |
Why?
|
Receptors, Interferon | 2 | 2015 | 14 | 0.160 |
Why?
|
Immunologic Factors | 1 | 2018 | 44 | 0.160 |
Why?
|
Male | 17 | 2021 | 18870 | 0.160 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2017 | 24 | 0.160 |
Why?
|
Arthritis, Rheumatoid | 1 | 2018 | 52 | 0.160 |
Why?
|
Receptors, Peptide | 1 | 2017 | 20 | 0.160 |
Why?
|
Amino Acid Sequence | 7 | 2012 | 1124 | 0.160 |
Why?
|
Aging | 2 | 2002 | 639 | 0.150 |
Why?
|
Survival Analysis | 3 | 2018 | 322 | 0.150 |
Why?
|
Antigens, Neoplasm | 1 | 2017 | 56 | 0.150 |
Why?
|
Microglia | 2 | 2021 | 152 | 0.150 |
Why?
|
Drug Design | 1 | 2018 | 154 | 0.150 |
Why?
|
Intramolecular Oxidoreductases | 1 | 2016 | 9 | 0.150 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2014 | 57 | 0.140 |
Why?
|
Immunity, Cellular | 3 | 2015 | 68 | 0.140 |
Why?
|
Lymphocyte Count | 4 | 2007 | 46 | 0.140 |
Why?
|
Glucocorticoids | 1 | 2016 | 80 | 0.140 |
Why?
|
Chromones | 1 | 2016 | 51 | 0.140 |
Why?
|
Serum Amyloid P-Component | 1 | 2016 | 20 | 0.140 |
Why?
|
Sulfonamides | 1 | 2016 | 75 | 0.140 |
Why?
|
Dendritic Cells | 2 | 2013 | 112 | 0.140 |
Why?
|
Intestines | 1 | 2016 | 63 | 0.140 |
Why?
|
Macrophages | 2 | 2011 | 431 | 0.140 |
Why?
|
Vaccines, Attenuated | 1 | 2016 | 72 | 0.140 |
Why?
|
Leukocytes, Mononuclear | 2 | 2015 | 224 | 0.140 |
Why?
|
Bacterial Proteins | 2 | 2010 | 520 | 0.130 |
Why?
|
Herpesvirus 4, Human | 1 | 2015 | 33 | 0.130 |
Why?
|
Phagocytosis | 1 | 2015 | 64 | 0.130 |
Why?
|
Clone Cells | 2 | 2007 | 46 | 0.130 |
Why?
|
Portraits as Topic | 1 | 2015 | 1 | 0.130 |
Why?
|
C-Reactive Protein | 1 | 2016 | 147 | 0.130 |
Why?
|
Sepsis | 1 | 2016 | 76 | 0.130 |
Why?
|
Anniversaries and Special Events | 1 | 2015 | 5 | 0.130 |
Why?
|
Kinetics | 2 | 2010 | 650 | 0.130 |
Why?
|
Autoantibodies | 3 | 2013 | 103 | 0.130 |
Why?
|
History, 21st Century | 1 | 2015 | 74 | 0.130 |
Why?
|
Antigens, CD19 | 1 | 2014 | 13 | 0.130 |
Why?
|
Periodicals as Topic | 1 | 2015 | 48 | 0.120 |
Why?
|
Immunotherapy, Adoptive | 2 | 2013 | 13 | 0.120 |
Why?
|
Mice, Neurologic Mutants | 1 | 2013 | 9 | 0.120 |
Why?
|
Receptors, HIV | 1 | 2013 | 5 | 0.120 |
Why?
|
Aluminum Hydroxide | 2 | 2004 | 7 | 0.120 |
Why?
|
Receptors, Pattern Recognition | 1 | 2013 | 9 | 0.110 |
Why?
|
Microscopy, Confocal | 1 | 2013 | 210 | 0.110 |
Why?
|
Receptors, Chemokine | 1 | 2013 | 68 | 0.110 |
Why?
|
Imaging, Three-Dimensional | 1 | 2013 | 89 | 0.110 |
Why?
|
Neuromyelitis Optica | 1 | 2012 | 1 | 0.110 |
Why?
|
Aquaporin 4 | 1 | 2012 | 4 | 0.110 |
Why?
|
Bacterial Infections | 1 | 2013 | 44 | 0.110 |
Why?
|
Host-Pathogen Interactions | 2 | 2013 | 179 | 0.110 |
Why?
|
Molecular Sequence Data | 6 | 2012 | 1490 | 0.110 |
Why?
|
Immunoassay | 1 | 2012 | 57 | 0.110 |
Why?
|
Toll-Like Receptor 2 | 1 | 2012 | 25 | 0.110 |
Why?
|
Magnetic Resonance Imaging | 1 | 2015 | 468 | 0.110 |
Why?
|
Enzyme Activation | 2 | 2010 | 423 | 0.110 |
Why?
|
Time Factors | 4 | 2017 | 1681 | 0.100 |
Why?
|
Fallopian Tubes | 1 | 2011 | 16 | 0.100 |
Why?
|
Receptors, IgE | 1 | 2011 | 22 | 0.100 |
Why?
|
Brain Chemistry | 3 | 2012 | 134 | 0.100 |
Why?
|
Antibodies, Blocking | 1 | 2011 | 11 | 0.100 |
Why?
|
Asparaginase | 1 | 2011 | 4 | 0.100 |
Why?
|
Cell Proliferation | 2 | 2013 | 1149 | 0.100 |
Why?
|
Lymph Nodes | 3 | 2005 | 67 | 0.100 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 2002 | 57 | 0.100 |
Why?
|
Drug Combinations | 1 | 2011 | 89 | 0.100 |
Why?
|
Axons | 1 | 2011 | 106 | 0.100 |
Why?
|
Peptides | 1 | 2013 | 308 | 0.100 |
Why?
|
Phagosomes | 1 | 2010 | 30 | 0.100 |
Why?
|
Models, Animal | 1 | 2011 | 131 | 0.100 |
Why?
|
Glycoproteins | 3 | 2005 | 100 | 0.090 |
Why?
|
Lung | 2 | 2010 | 413 | 0.090 |
Why?
|
Endopeptidases | 2 | 2008 | 58 | 0.090 |
Why?
|
Butadienes | 1 | 2009 | 30 | 0.090 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 2009 | 39 | 0.090 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2009 | 27 | 0.090 |
Why?
|
Administration, Intranasal | 5 | 2009 | 77 | 0.090 |
Why?
|
Nitriles | 1 | 2009 | 66 | 0.090 |
Why?
|
Escherichia coli Proteins | 1 | 2011 | 119 | 0.090 |
Why?
|
Microwaves | 3 | 2014 | 26 | 0.090 |
Why?
|
Protein Kinase Inhibitors | 1 | 2009 | 117 | 0.090 |
Why?
|
T-Cell Antigen Receptor Specificity | 1 | 2008 | 4 | 0.090 |
Why?
|
Contact Inhibition | 1 | 2008 | 4 | 0.080 |
Why?
|
Acute Disease | 3 | 2005 | 141 | 0.080 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2009 | 146 | 0.080 |
Why?
|
Guinea Pigs | 2 | 2007 | 141 | 0.080 |
Why?
|
Vaginal Diseases | 1 | 2008 | 9 | 0.080 |
Why?
|
Immunity, Innate | 2 | 2008 | 135 | 0.080 |
Why?
|
Proto-Oncogene Proteins | 1 | 2009 | 229 | 0.080 |
Why?
|
Clinical Trials as Topic | 1 | 2009 | 195 | 0.080 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2007 | 445 | 0.080 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2007 | 26 | 0.080 |
Why?
|
Infusions, Parenteral | 1 | 2007 | 12 | 0.080 |
Why?
|
Immunoglobulin Class Switching | 1 | 2007 | 20 | 0.080 |
Why?
|
DNA Replication | 1 | 2008 | 148 | 0.080 |
Why?
|
Aged | 2 | 2017 | 6448 | 0.070 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2006 | 29 | 0.070 |
Why?
|
Hypersensitivity | 1 | 2006 | 28 | 0.070 |
Why?
|
Interleukin-2 | 3 | 2016 | 87 | 0.070 |
Why?
|
Age Factors | 2 | 2007 | 1007 | 0.070 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2007 | 164 | 0.070 |
Why?
|
Membrane Proteins | 1 | 2009 | 486 | 0.070 |
Why?
|
Dose-Response Relationship, Immunologic | 2 | 2003 | 23 | 0.070 |
Why?
|
Allergens | 1 | 2006 | 58 | 0.070 |
Why?
|
Crosses, Genetic | 1 | 2005 | 48 | 0.070 |
Why?
|
Glutamate Decarboxylase | 2 | 1996 | 17 | 0.070 |
Why?
|
Vaccines, Synthetic | 2 | 2018 | 72 | 0.070 |
Why?
|
Microscopy, Fluorescence | 1 | 2006 | 240 | 0.060 |
Why?
|
Diabetes Mellitus, Type 1 | 2 | 1996 | 58 | 0.060 |
Why?
|
Oligodeoxyribonucleotides | 2 | 2018 | 52 | 0.060 |
Why?
|
Skin Transplantation | 1 | 2004 | 5 | 0.060 |
Why?
|
Recombinant Fusion Proteins | 2 | 2018 | 286 | 0.060 |
Why?
|
Graft Rejection | 1 | 2004 | 38 | 0.060 |
Why?
|
Myocardium | 2 | 2021 | 224 | 0.060 |
Why?
|
Down-Regulation | 2 | 2003 | 420 | 0.060 |
Why?
|
Gene Transfer Techniques | 1 | 2003 | 43 | 0.060 |
Why?
|
Interleukin-5 | 2 | 2000 | 7 | 0.060 |
Why?
|
Immune Sera | 1 | 2003 | 59 | 0.060 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2003 | 27 | 0.060 |
Why?
|
Magnetics | 2 | 2012 | 36 | 0.060 |
Why?
|
Intracellular Fluid | 1 | 2002 | 26 | 0.060 |
Why?
|
Genetic Predisposition to Disease | 1 | 2005 | 528 | 0.050 |
Why?
|
Antibody Formation | 2 | 2006 | 73 | 0.050 |
Why?
|
Complementarity Determining Regions | 1 | 2002 | 8 | 0.050 |
Why?
|
Wound Healing | 1 | 2003 | 69 | 0.050 |
Why?
|
Bone Marrow Cells | 2 | 2013 | 75 | 0.050 |
Why?
|
Epitope Mapping | 1 | 2001 | 31 | 0.050 |
Why?
|
Binding, Competitive | 1 | 2001 | 103 | 0.050 |
Why?
|
Epitopes | 3 | 2005 | 145 | 0.050 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 1 | 2021 | 14 | 0.050 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2003 | 200 | 0.050 |
Why?
|
Blood-Brain Barrier | 1 | 2003 | 153 | 0.050 |
Why?
|
Brain Injuries | 1 | 2003 | 104 | 0.050 |
Why?
|
Vaccines | 1 | 2002 | 49 | 0.050 |
Why?
|
Clonal Deletion | 1 | 2000 | 3 | 0.050 |
Why?
|
Severity of Illness Index | 1 | 2003 | 608 | 0.050 |
Why?
|
Glycosides | 1 | 2000 | 19 | 0.050 |
Why?
|
Triterpenes | 1 | 2000 | 12 | 0.050 |
Why?
|
Vagina | 2 | 2011 | 81 | 0.050 |
Why?
|
Cell Death | 2 | 2012 | 260 | 0.050 |
Why?
|
Protein Binding | 2 | 2018 | 913 | 0.040 |
Why?
|
Mycobacterium Infections | 1 | 1999 | 16 | 0.040 |
Why?
|
Arthritis, Reactive | 1 | 1998 | 1 | 0.040 |
Why?
|
Lymphocyte Function-Associated Antigen-1 | 1 | 1998 | 5 | 0.040 |
Why?
|
Lyme Disease | 1 | 1998 | 16 | 0.040 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2000 | 283 | 0.040 |
Why?
|
Lipoproteins | 1 | 1998 | 61 | 0.040 |
Why?
|
Antigens, Protozoan | 1 | 2018 | 71 | 0.040 |
Why?
|
Computational Biology | 2 | 2011 | 275 | 0.040 |
Why?
|
T-Lymphocytes, Helper-Inducer | 2 | 1998 | 41 | 0.040 |
Why?
|
Algorithms | 2 | 2017 | 435 | 0.040 |
Why?
|
Early Diagnosis | 1 | 2017 | 62 | 0.040 |
Why?
|
Patient Selection | 1 | 2018 | 154 | 0.040 |
Why?
|
Drug Delivery Systems | 1 | 2018 | 182 | 0.040 |
Why?
|
Immunity | 1 | 2016 | 51 | 0.030 |
Why?
|
Herpesvirus 6, Human | 1 | 2015 | 4 | 0.030 |
Why?
|
Herpesvirus 3, Human | 1 | 2015 | 12 | 0.030 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2015 | 15 | 0.030 |
Why?
|
Lipopolysaccharides | 1 | 2016 | 200 | 0.030 |
Why?
|
Spectrin | 1 | 2014 | 4 | 0.030 |
Why?
|
Synapsins | 1 | 2014 | 7 | 0.030 |
Why?
|
Nanoparticles | 1 | 2018 | 294 | 0.030 |
Why?
|
Alleles | 2 | 2006 | 284 | 0.030 |
Why?
|
Receptor, Macrophage Colony-Stimulating Factor | 1 | 2013 | 3 | 0.030 |
Why?
|
Antigens, Ly | 1 | 2013 | 7 | 0.030 |
Why?
|
Chimera | 1 | 2013 | 15 | 0.030 |
Why?
|
Pneumonia, Bacterial | 1 | 2013 | 21 | 0.030 |
Why?
|
Lymphoid Tissue | 1 | 2013 | 17 | 0.030 |
Why?
|
Demyelinating Diseases | 1 | 2013 | 15 | 0.030 |
Why?
|
Interleukin-1 | 1 | 2013 | 33 | 0.030 |
Why?
|
Adaptive Immunity | 1 | 2013 | 27 | 0.030 |
Why?
|
Immunity, Active | 1 | 2013 | 6 | 0.030 |
Why?
|
Cell Degranulation | 1 | 2013 | 10 | 0.030 |
Why?
|
Chlamydia trachomatis | 1 | 2013 | 66 | 0.030 |
Why?
|
Mutation | 2 | 2011 | 1023 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2012 | 188 | 0.030 |
Why?
|
Longitudinal Studies | 1 | 2015 | 841 | 0.030 |
Why?
|
Toll-Like Receptor 4 | 1 | 2012 | 58 | 0.030 |
Why?
|
Perforin | 1 | 2011 | 9 | 0.030 |
Why?
|
Directed Molecular Evolution | 1 | 2011 | 5 | 0.030 |
Why?
|
Genetic Drift | 1 | 2011 | 3 | 0.030 |
Why?
|
Tandem Mass Spectrometry | 1 | 2012 | 173 | 0.030 |
Why?
|
Analysis of Variance | 1 | 2012 | 528 | 0.020 |
Why?
|
Protein Transport | 1 | 2012 | 286 | 0.020 |
Why?
|
Coculture Techniques | 1 | 2011 | 96 | 0.020 |
Why?
|
Prospective Studies | 1 | 2015 | 1353 | 0.020 |
Why?
|
Receptors, Interleukin-4 | 1 | 2010 | 10 | 0.020 |
Why?
|
Peptide Library | 1 | 2011 | 25 | 0.020 |
Why?
|
Mannose-Binding Lectins | 1 | 2010 | 14 | 0.020 |
Why?
|
Organelles | 1 | 2010 | 23 | 0.020 |
Why?
|
Macrophages, Alveolar | 1 | 2010 | 31 | 0.020 |
Why?
|
Catalytic Domain | 1 | 2011 | 97 | 0.020 |
Why?
|
Lectins, C-Type | 1 | 2010 | 35 | 0.020 |
Why?
|
Colony Count, Microbial | 1 | 2010 | 66 | 0.020 |
Why?
|
Blotting, Western | 1 | 2012 | 834 | 0.020 |
Why?
|
Oligopeptides | 1 | 2010 | 97 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2016 | 2128 | 0.020 |
Why?
|
Cricetinae | 1 | 2010 | 217 | 0.020 |
Why?
|
Antibodies, Bacterial | 1 | 2010 | 107 | 0.020 |
Why?
|
Hela Cells | 1 | 2011 | 344 | 0.020 |
Why?
|
Receptors, Cell Surface | 1 | 2010 | 135 | 0.020 |
Why?
|
Caspase 3 | 1 | 2010 | 194 | 0.020 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 1990 | 37 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2011 | 383 | 0.020 |
Why?
|
Adult | 4 | 2015 | 11034 | 0.020 |
Why?
|
Intracellular Space | 1 | 2008 | 35 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 2010 | 396 | 0.020 |
Why?
|
beta 2-Microglobulin | 1 | 2008 | 8 | 0.020 |
Why?
|
Recombinant Proteins | 2 | 2006 | 485 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 1990 | 178 | 0.020 |
Why?
|
Gene Expression Regulation | 2 | 2010 | 968 | 0.020 |
Why?
|
beta-Glucans | 1 | 2007 | 10 | 0.020 |
Why?
|
Cell Adhesion | 1 | 2008 | 209 | 0.020 |
Why?
|
Models, Molecular | 1 | 2011 | 751 | 0.020 |
Why?
|
HLA Antigens | 1 | 1987 | 19 | 0.020 |
Why?
|
Interferon Type I | 1 | 1987 | 17 | 0.020 |
Why?
|
Isoflavones | 1 | 2007 | 125 | 0.020 |
Why?
|
Antigens, Plant | 1 | 2006 | 3 | 0.020 |
Why?
|
Genes, MHC Class II | 1 | 2006 | 20 | 0.020 |
Why?
|
Protein Structure, Quaternary | 1 | 2006 | 61 | 0.020 |
Why?
|
Solubility | 1 | 2006 | 115 | 0.020 |
Why?
|
Heart | 1 | 2007 | 178 | 0.020 |
Why?
|
Islets of Langerhans | 2 | 1996 | 9 | 0.020 |
Why?
|
Plant Proteins | 1 | 2006 | 93 | 0.020 |
Why?
|
Mice, Inbred NOD | 2 | 1996 | 43 | 0.020 |
Why?
|
Sex Factors | 1 | 2007 | 859 | 0.020 |
Why?
|
Fibrosarcoma | 1 | 2003 | 7 | 0.010 |
Why?
|
Retroviridae | 1 | 2003 | 22 | 0.010 |
Why?
|
Exons | 1 | 2003 | 80 | 0.010 |
Why?
|
Models, Genetic | 1 | 2003 | 149 | 0.010 |
Why?
|
Transcriptional Activation | 1 | 2003 | 164 | 0.010 |
Why?
|
Histocompatibility Testing | 1 | 2002 | 7 | 0.010 |
Why?
|
Carcinogens | 1 | 2003 | 117 | 0.010 |
Why?
|
Immunophenotyping | 1 | 2002 | 53 | 0.010 |
Why?
|
Extracellular Space | 1 | 2002 | 33 | 0.010 |
Why?
|
Influenza A virus | 1 | 2002 | 25 | 0.010 |
Why?
|
Benzo(a)pyrene | 1 | 2003 | 122 | 0.010 |
Why?
|
Chronic Disease | 1 | 2005 | 469 | 0.010 |
Why?
|
Fibroblasts | 1 | 2003 | 252 | 0.010 |
Why?
|
Thymectomy | 1 | 2000 | 1 | 0.010 |
Why?
|
Viral Proteins | 1 | 2002 | 172 | 0.010 |
Why?
|
DNA Damage | 1 | 2003 | 341 | 0.010 |
Why?
|
Models, Immunological | 1 | 2000 | 20 | 0.010 |
Why?
|
Phenotype | 1 | 2003 | 650 | 0.010 |
Why?
|
GATA3 Transcription Factor | 1 | 2000 | 4 | 0.010 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 2000 | 25 | 0.010 |
Why?
|
Lymphocyte Transfusion | 1 | 2000 | 2 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2003 | 550 | 0.010 |
Why?
|
Interleukin-10 | 1 | 2000 | 69 | 0.010 |
Why?
|
Cell Membrane | 1 | 2002 | 360 | 0.010 |
Why?
|
Administration, Oral | 1 | 2000 | 212 | 0.010 |
Why?
|
DNA Primers | 1 | 2000 | 269 | 0.010 |
Why?
|
Alum Compounds | 1 | 1999 | 1 | 0.010 |
Why?
|
Trans-Activators | 1 | 2000 | 167 | 0.010 |
Why?
|
Mice, Inbred DBA | 1 | 1999 | 69 | 0.010 |
Why?
|
Stem Cells | 1 | 2000 | 132 | 0.010 |
Why?
|
Borrelia burgdorferi Group | 1 | 1998 | 1 | 0.010 |
Why?
|
Synovial Fluid | 1 | 1998 | 4 | 0.010 |
Why?
|
Antigens, Surface | 1 | 1998 | 39 | 0.010 |
Why?
|
Cross Reactions | 1 | 1998 | 83 | 0.010 |
Why?
|
Bacterial Outer Membrane Proteins | 1 | 1998 | 50 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2000 | 522 | 0.010 |
Why?
|
Immunoglobulin Isotypes | 1 | 1996 | 16 | 0.010 |
Why?
|
Middle Aged | 2 | 2002 | 9642 | 0.010 |
Why?
|
Child | 1 | 1998 | 2875 | 0.010 |
Why?
|
Leucovorin | 1 | 1990 | 4 | 0.010 |
Why?
|
Vincristine | 1 | 1990 | 13 | 0.010 |
Why?
|
Prednisone | 1 | 1990 | 26 | 0.010 |
Why?
|
Bleomycin | 1 | 1990 | 18 | 0.010 |
Why?
|
Methotrexate | 1 | 1990 | 20 | 0.010 |
Why?
|
Cyclophosphamide | 1 | 1990 | 52 | 0.010 |
Why?
|
Doxorubicin | 1 | 1990 | 80 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 1990 | 133 | 0.010 |
Why?
|
Adolescent | 1 | 1998 | 5035 | 0.000 |
Why?
|
HLA-A2 Antigen | 1 | 1987 | 3 | 0.000 |
Why?
|
HLA-B7 Antigen | 1 | 1987 | 2 | 0.000 |
Why?
|
Colony-Forming Units Assay | 1 | 1987 | 12 | 0.000 |
Why?
|
Transfection | 1 | 1987 | 496 | 0.000 |
Why?
|